Seeing Is Believing
BCAX is currently covered by 5 analysts with an average price target of $35.25. This is a potential upside of $15.6 (55.49%) from yesterday's end of day stock price of $22.67.
Bicara Therapeutics Common Stock's activity chart (see below) currently has 18 price targets and 26 ratings on display. The stock rating distribution of BCAX is 72.73% BUY and 27.27% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.08% with an average time for these price targets to be met of 49.92 days.
Highest price target for BCAX is $48, Lowest price target is $16, average price target is $35.25.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 12-Aug-2026. First documented stock forecast 08-Oct-2024.
Currently out of the existing stock ratings of BCAX, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Feb-2025
$33
$10.19 (44.67%)
$30
1 months 4 days ago
(12-Aug-2026)
2/5 (40%)
$8.37 (33.98%)
137
Hold Since 10-Nov-2025
$23
$0.19 (0.83%)
$16
1 months 4 days ago
(12-Aug-2026)
1/4 (25%)
$-1.63 (-6.62%)
30
Buy Since 06-Dec-2024
$42
$15.13 (56.31%)
$40
5 months 16 days ago
(31-Mar-2026)
0/6 (0%)
$22.11 (111.16%)
Buy Since 08-Oct-2024
$48
$21.13 (78.64%)
$48
10 months 26 days ago
(21-Oct-2025)
0/5 (0%)
$30.94 (181.36%)
Buy Since 09-Sep-2025
$22
$-4.87 (-18.12%)
1 years 7 days ago
(09-Sep-2025)
1/1 (100%)
$9.54 (76.57%)
216
What is BCAX (Bicara Therapeutics Common Stock) average time for price targets to be met?
Which analyst most recently updated their price target on BCAX (Bicara Therapeutics Common Stock)?
Which analyst has the most public recommendations on BCAX (Bicara Therapeutics Common Stock)?
Which analyst is the currently most bullish on BCAX (Bicara Therapeutics Common Stock)?
Which analyst is the currently most reserved on BCAX (Bicara Therapeutics Common Stock)?